Please click to view.
Paul Angulo, MD, David E. Kleiner, MD, PhD, Sanne Dam-Larsen, MD, PhD, Leon A. Adams, MBBS, PhD, Einar S. Bjornsson, MD, Phunchai Charatcharoenwitthaya, MD, Peter R. Mills, MD, Jill C. Keach, Heather D. Lafferty, MB, ChB, Alisha Stahler, Svanhildur Haflidadottir, MD, and Flemming Bendtsen, MD, PhD.
Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology. 2015 August ; 149(2): 389–397.e10.
Brittany N. Bohinc, Gregory Michelotti, Guanhua Xie, Herbert Pang, Ayako Suzuki, Cynthia D. Guy, Dawn Piercy, Leandi Kruger, Marzena Swiderska-Syn, Mariana Machado, Thiago Pereira, Ann Marie Zavacki, Manal Abdelmalek, and Anna Mae Diehl.
Repair-Related Activation of Hedgehog Signaling in Stromal Cells Promotes Intrahepatic Hypothyroidism.
Endocrinology. November 2014, 155(11):4591–4601.
Anna M. Diehl, M.D., and Christopher Day, M.D.
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
N Engl J Med. 2017;377:2063-72.
Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, and Arun J. Sanyal.
Modeling the Epidemic of Nonalcoholic Fatty Liver Disease Demonstrates an Exponential Increase in Burden of Disease.
HEPATOLOGY. VOL. 67, NO. 1, 2018.
Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, Kim Pfotenhauer, Vincent Wai-Sun Wong, Eugene Wright, Manal F. Abdelmalek, Stephen A. Harrison, Rohit Loomba, Christos S. Mantzoros, Elisabetta Bugianesi, Robert H. Eckel, Lee M. Kaplan, Hashem B. El-Serag, and Kenneth Cusi.
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
Rohit Loomba, Leon A Adams.
Advances in non-invasive assessment of hepatic fibrosis.
Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo, Giacomo Zoppini, Enzo Bonora, Christos S. Mantzoros, and Giovanni Targher.
Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
THYROID. Volume 28, Number 10, 2018.
Mary E. Rinella, MD, Brent A. Neuschwander-Tetri, MD, Mohammad Shadab Siddiqui, MD, Manal F. Abdelmalek, MD, MPH, Stephen Caldwell, MD, Diana Barb, MD, David E. Kleiner, MD, PhD, Rohit Loomba, MD, MHSc.
AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease
Hepatology. Publish Ahead of Print. DOI:10.1097/HEP.0000000000000323.
Megan J. Ritter, Izuki Amano, and Anthony N. Hollenberg.
Thyroid Hormone Signaling and the Liver.
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/HEP.31296. This article is protected by copyright. All rights reserved.
Adam C. Sheka, MD; Oyedele Adeyi, MD; Julie Thompson, MD, MPH; Bilal Hameed, MD; Peter A. Crawford, MD, PhD; Sayeed Ikramuddin, MD, MHA.
Nonalcoholic Steatohepatitis A Review.
JAMA. 2020;323(12):1175-1183. Corrected on April 28, 2020.
Rohit A. Sinha (PhD), Eveline Bruinstroop (MD PhD), Brijesh K. Singh (PhD) and Paul M. Yen (MD).
Non‐alcoholic fatty liver disease and hypercholesterolemia: Roles of thyroid hormones, metabolites, and agonists.
Thyroid. This paper has been peer‐reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Elliot B. Tapper, M.D., and Anna S.-F. Lok, M.D.
Use of Liver Imaging and Biopsy in Clinical Practice.
N Engl J Med. 2017;377:756-68.
Giovanni Targher, Herbert Tilg, Christopher D Byrne.
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.
Lancet Gastroenterol Hepatol. 2021; 6: 578–88.
Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, and Mark Wymer.
Global Epidemiology of Nonalcoholic Fatty Liver Disease—Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes.
Hepatology. 2016 Jul;64(1):73-84.
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update.
J Hepatol. 2021 Sep;75(3):659-689.